| The complement system in COVID-19: friend and foe? A Java, AJ Apicelli, MK Liszewski, A Coler-Reilly, JP Atkinson, AHJ Kim, ... JCI insight 5 (15), e140711, 2020 | 383 | 2020 |
| Hope on the horizon: novel fungal treatments in development AM Rauseo, A Coler-Reilly, L Larson, A Spec Open forum infectious diseases 7 (2), ofaa016, 2020 | 202 | 2020 |
| HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells N Araya, T Sato, H Ando, U Tomaru, M Yoshida, A Coler-Reilly, ... The Journal of clinical investigation 124 (8), 3431-3442, 2014 | 119 | 2014 |
| Mogamulizumab (Anti-CCR4) in HTLV-1–associated myelopathy T Sato, ALG Coler-Reilly, N Yagishita, N Araya, E Inoue, R Furuta, ... New England Journal of Medicine 378 (6), 529-538, 2018 | 113 | 2018 |
| CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis T Sato, A Coler-Reilly, A Utsunomiya, N Araya, N Yagishita, H Ando, ... PLoS neglected tropical diseases 7 (10), e2479, 2013 | 110 | 2013 |
| Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy H Ando, T Sato, U Tomaru, M Yoshida, A Utsunomiya, J Yamauchi, ... Brain 136 (9), 2876-2887, 2013 | 106 | 2013 |
| Pathogenesis of hand-foot syndrome induced by PEG-modified liposomal doxorubicin N Yokomichi, T Nagasawa, A Coler-Reilly, H Suzuki, Y Kubota, ... Human cell 26, 8-18, 2013 | 99 | 2013 |
| The geographic distribution of dimorphic mycoses in the United States for the modern era PB Mazi, JM Sahrmann, MA Olsen, A Coler-Reilly, AM Rauseo, M Pullen, ... Clinical Infectious Diseases 76 (7), 1295-1301, 2023 | 79 | 2023 |
| Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19 SE Sattui, JW Liew, ER Graef, A Coler-Reilly, F Berenbaum, ... Expert Review of Clinical Immunology 16 (7), 659-666, 2020 | 69 | 2020 |
| Proposal of classification criteria for HTLV-1-associated myelopathy/tropical spastic paraparesis disease activity T Sato, N Yagishita, K Tamaki, E Inoue, D Hasegawa, M Nagasaka, ... Frontiers in microbiology 9, 1651, 2018 | 69 | 2018 |
| HTLV-1 induces a Th1-like state in CD4+ CCR4+ T cells that produces an inflammatory positive feedback loop via astrocytes in HAM/TSP Y Yamano, A Coler-Reilly Journal of neuroimmunology 304, 51-55, 2017 | 50 | 2017 |
| Nation-wide epidemiological study of Japanese patients with rare viral myelopathy using novel registration system (HAM-net) ALG Coler-Reilly, N Yagishita, H Suzuki, T Sato, N Araya, E Inoue, ... Orphanet journal of rare diseases 11, 1-17, 2016 | 50 | 2016 |
| Mogamulizumab, an Anti-CCR4 Antibody, Targets Human T-Lymphotropic Virus Type 1–infected CD8+ and CD4+ T Cells to Treat Associated Myelopathy J Yamauchi, A Coler-Reilly, T Sato, N Araya, N Yagishita, H Ando, ... The Journal of Infectious Diseases 211 (2), 238-248, 2015 | 47 | 2015 |
| Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1–associated myelopathy/tropical spastic paraparesis M Nagasaka, M Yamagishi, N Yagishita, N Araya, S Kobayashi, ... Proceedings of the National Academy of Sciences 117 (21), 11685-11691, 2020 | 44 | 2020 |
| Effectiveness of daily prednisolone to slow progression of human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis: a multicenter retrospective … ALG Coler-Reilly, T Sato, T Matsuzaki, M Nakagawa, M Niino, M Nagai, ... Neurotherapeutics 14 (4), 1084-1094, 2017 | 41 | 2017 |
| Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan S Tsutsumi, T Sato, N Yagishita, J Yamauchi, N Araya, D Hasegawa, ... Orphanet Journal of Rare Diseases 14, 1-13, 2019 | 33 | 2019 |
| Efficacy of corticosteroid therapy for HTLV-1-associated myelopathy: a randomized controlled trial (HAMLET-P) J Yamauchi, K Tanabe, T Sato, M Nakagawa, E Matsuura, Y Tsuboi, ... Viruses 14 (1), 136, 2022 | 27 | 2022 |
| Cerebrospinal fluid CXCL10 as a candidate surrogate marker for HTLV-1-associated myelopathy/tropical spastic paraparesis K Tamaki, T Sato, J Tsugawa, S Fujioka, N Yagishita, N Araya, ... Frontiers in microbiology 10, 2110, 2019 | 26 | 2019 |
| Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions: A case report Y Terada, K Kamoi, K Ohno-Matsui, K Miyata, C Yamano, A Coler-Reilly, ... Medicine 96 (6), e6021, 2017 | 25 | 2017 |
| Use of cerebrospinal fluid CXCL10 and neopterin as biomarkers in HTLV-1-associated myelopathy/tropical spastic paraparesis treated with steroids J Yamauchi, T Sato, N Yagishita, N Araya, D Hasegawa, S Tsutsumi, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (3), 321-323, 2020 | 21 | 2020 |
Alfred H.J. KimWashington University School of Medicineยืนยันอีเมลแล้วที่ wustl.edu